01/22/2010 - GE Healthcare, a British subsidiary of multinational giant General Electric, is suing Henrik Thomsen, a senior radiologist and professor of radiology, for sounding the alarm about the dangers of the company's medical imaging drug, Omniscan. After witnessing kidney patients who had received the drug develop potentially fatal conditions, Thomsen publicly exposed the drug's dangers which caused a firestorm of controversy. More ::

01/20/2010 - Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology. More ::

12/30/2009 - In patients with renal function impairment, the use of gadolinium-based contrast agents is risky because it can lead to the development of nephrogenic systemic fibrosis, according to a study in the January issue of The Journal of Urology. More ::

10/20/2009 - In May 2006, medical regulators in Denmark issued a warning that signaled trouble for General Electric. Danish researchers noted that, over a four-year period, 25 patients in Denmark and Austria had suffered a rare and crippling disease after undergoing an MRI, the scanning procedure used to diagnose everything from brain tumors to blown knees. More ::

08/26/2009 - Gadolinium is a contrast agent used in MRI. Gadolinium can cause side effects ranging from minor skin irritations to debilitating, and sometimes fatal, Nephrogenic Systemic Fibrosis (NSF). Gadolinium is especially dangerous for patients with poor renal function. Below is a list of side effects associated with Gadolinium, including the symptoms of NSF. More ::

07/14/2009 - A Warwick woman has joined 516 other plaintiffs in a massive lawsuit against pharmaceutical companies that make certain dyes used for magnetic resonance imaging (MRI). The woman, who did not want to be identified, was diagnosed with nephrogenic systemic fibrosis (NSF) in 2006 after being injected with a contrast-agent made with gadolinium. More ::

04/17/2009 - Bayer AG, Germany’s largest drugmaker, has started settling lawsuits over its Magnevist contrast agent used in diagnostic imaging tests. The company began negotiations in about 40 cases linking the product to a disease that hardens organs, Peter Burg, an attorney with Burg Simpson Eldredge Hersh Jardine PC in Englewood, Colorado, said today. More ::

04/02/2009 - Meta-analysis reveals a strong association between contrast agents and nephrogenic systemic fibrosis. Evidence suggests a potentially causal link between gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) in patients with advanced kidney disease, according to researchers. More ::

03/16/2009 - According to U.S. District Judge Dan Polster, Bayer Healthcare has initiated settlement negotiations with a number of plaintiffs who have filed Nephrogenic Systemic Fibrosis lawsuits after receiving the gadolinium-based Magnevist MRI contrast agent. More ::

03/08/2009 - The American Society of Anesthesiologists (ASA) Task Force on Anesthetic Care for Magnetic Resonance Imaging (MRI) has issued a practice advisory in this area and published it in the March issue of Anesthesiology. Anesthetic care for MRI encompasses provision of moderate and deep sedation, monitored anesthesia care, general anesthesia, and ventilatory and critical care support. More ::

01/14/2009- Cleveland, OH: Magnetic resonance imaging, known more commonly as an MRI, is one of the super tools of modern medicine. It provides doctors with a detailed picture of what’s going on deep inside a patient’s body. However, there is evidence to show that one of the chemical agents used to produce MRI can be extremely toxic to people with kidney disease. More ::

12/22/2008- Lawyers for the plaintiffs and lawyers for the manufacturers of gadolinium based MRI contract agents, have filed a joint list of 193 NSF lawsuits which are eligible to be among the first cases prepared for trial in the consolidated federal litigation. More ::

12/14/2008- A new study of people with Nephrogenic Systemic Fibrosis (NSF) has again found a strong link between the condition and the use of gadolinium contrast dyes. The study, conducted by researchers at Vanderbilt University, concludes that gadolinium contrast dyes should be used "judiciously" in patients with pre-existing kidney disease, and their benefits should be carefully weighed against their risks. More ::

09/24/2008- According to documents filed in federal court, the makers of gadolinium-based contrast agents currently face 391 lawsuits filed by individuals who allege that they developed a rare condition known as NSF, or nephrogenic systemic fibrosis, after an enhanced MRI.
More ::

09/18/2008- The relatively new medical device is gadolinium-based contrast agent (GBCA or gadolinium) used during certain MRI or similar procedures. The new kidney related disease that is little more than a decade old is called Nephrogenic Systemic Fibrosis (NSF). More ::

08/14/2008- Makers of MRI contrast dyes are being sued by claimants who say they developed a skin hardening condition from exposure to a metal that is highly toxic in its free state. More ::

7/31/2008- More and more people are discovering that they are allergic to MRI gadolinium-based contrast dyes. Unfortunately, they are discovering this well after the dye has been used and has caused serious health problems. More ::

07/27/2008- Springtown, TX: It really should be simple: have an MRI procedure done, walk away from the MRI in the same health as when you walked in. However, that is not everyone's experience. More ::

07/22/2008- Gadolinium-based contrast material used in magnetic resonance imaging (MRI) increases the risk for nephrogenic systemic fibrosis (NSF), according to a report in the June issue of the American Journal of Kidney Diseases. More ::

06/24/2008- Fred has been diagnosed with NFS (Nephrogenic Systemic Fibrosis, also known NFD). It is a crippling and horrific disease directly associated with exposure to gadolinium-based contrast agents used in MRIs. More ::

06/21/2008-Frank has been diagnosed with NFS (Nephrogenic Systemic Fibrosis, also known NFD). It is a crippling and horrific disease directly associated with exposure to gadolinium-based contrast agents used in MRIs. More ::

06/18/2008- The largely man-made disease most closely associated with the use of gadolinium-based contrasting agents in MRI procedures is just a little more than 10 years old, and is a horrific affliction--called NSF or NFD More ::

06/13/2008- Leon L. lives in a state of uncertainty: he has had six MRIs and each time, was injected with a gadolinium-based contrast agent. Nobody can give him a definite answer whether or not the side effects he has developed will lead to NSF—nephrogenic systemic fibrosis. More ::

06/11/2008- There isn't a man or woman alive who doesn't want to feel comfortable in his or her own skin. It's become a catch phrase for emotional well-being. More ::

06/02/2008- As important as the MRI is in detecting disease and abnormalities deep within the human body, the process carries certain risks that have only recently come to light. More ::

05/30/2008- In some patients with kidney problems, a common dye used in magnetic resonance imaging (MRI) tests may lead to an incurable and potentially fatal disease that causes skin to turn hard and immobile. More ::

05/26/2008- When asking about gadolinium side effects patients are more often than not referring to Nephrogenic Systemic Fibrosis symptoms, as the symptoms of NSF are essentially the side effects of gadolinium (used as a contrast agent during an MRI) combined with renal failure / poorly functioning kidneys that are unable to properly expel the gadolinium from the patient’s system. More ::

4/27/2008 - Having a Magnetic Resonance Imaging (MRI) scan using the contrasting agent gadolinium during the procedure may induce the onset of a debilitating malady commonly known as NSF/NFD. More ::

03/19/2008 - Since its development in the mid 1970s, Magnetic Resonance Imaging, or MRI, has grown into a mainstream diagnostic imaging tool used in a wide variety of conditions. More ::

03/17/2008 - William Paschal and his wife Patricia accuse Bayer Healthcare Pharmaceuticals of manufacturing and releasing a compound into the market consisting of highly toxic metals that allegedly causes consumers to suffer a painful and deadly disease. More::

03/07/2008 - A growing list of suits are being filed against makers of gadolinium contrast dyes used to enhance MRI results, which are thought to be causing some cases of a progressive, untreatable and possibly fatal disease known as Nephrogenic Systemic Fibrosis or Nephorgenic Fibrosing Dermopathy. More ::

03/06/2008 - MRI (magnetic resonance imaging) is a common and, in most cases, safe medical test. However, for people with kidney disease, MRI can cause a rare disease called NSF/NFD (nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy). More ::

02/17/2008 - Hundreds of people are becoming afflicted with an incurable disease caused by a simple Magnetic Resonance Imaging (MRI) procedure. The disease is Nefrogenic Systemic Fibrosis (NSF) and many medical professionals believe the only way to contract the disease is from gadolinium, a dye used in certain MRI procedures.

More ::

01/17/2008 - Allergic-like reactions to intravenous contrast media containing gadolinium are rare in children and adults, according to a report in the December American Journal of Radiology. More ::

12/28/2007 - Allergic-like reactions to gadolinium-containing contrast injections in adults and pediatric patients (those younger than 19 years of age) are rare, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor. More ::

11/20/2007 - Bayer HealthCare Pharmaceuticals, Inc a leader in diagnostic imaging, announced today that the company has been awarded a three-year contract by MedAssets Supply Chain Systems, one of the nation's largest group purchasing organizations, to provide Magnevist(R) (gadopentetate dimeglumine) More ::

11/19/2007 - The number of people with kidney disease is increasing, but experts say that not all cases can be blamed on increasing rates of obesity, diabetes and hypertension that are so often cited as likely causes. More ::

11/17/2007 - LegalView, your source for everything legal has announced it will soon launch a Nephrogenic Systemic Fibrosis blog to further inform victims of the rare disease. Nephrogenic Systemic Fibrosis (NSF) is a rare and potentially fatal illness that is associated with those who have dealt with serious kidney disease. More ::

11/07/2007 - A growing number of people are becoming afflicted with an incurable, man-made disease that is related to a common medical procedure performed every single day in this country, a KCRA 3 investigation has found. Sarah Fracella is one the victims. More ::

10/23/2007 - NEPHROGENIC systemic fibrosis (NSF) is a new fibrotic skin disease entity that was first recognized in 1997 in 15 patients re-ceiving hemodialysis. More ::

10/22/2007 - SCOTTISH RESEARCHERS have confirmed an association between gadolinium-based contrast agent use and development of nephrogenic systemic fibrosis (NSF) in patients with renal failure undergoing renal replacement therapy (RRT), according to a report in Radiology (2007; published online ahead of print). More ::

10/19/2007 - Transglutaminases are upregulated in nephrogenic systemic fibrosis (NSF), a condition that can occur in renal failure patients after gadolinium contrast exposure, according to a report in the October issue of the American Journal of Dermatopathology. More ::

10/08/2007 - A painful and debilitating condition that affects patients with kidney failure may be more common than previously believed and appears to be strongly associated with prior exposure to certain contrast agents used in imaging studies. More ::

10/01/2007 - Dialysis patients exposed to gadolinium-containing contrast material during MRI may be at risk for nephrogenic systemic fibrosis, researchers found. More ::

09/28/2007 - Nephrogenic systemic fibrosis (NSF) is a newly identified debilitating and painful condition that affects patients with kidney failure and is characterized by a thickening and hardening of the skin. It usually affects the arms and legs but it can also affect internal organs and can progress so rapidly that patients can be immobilized and wheelchair-bound within a few weeks. Although it is not clear what causes NSF, the condition has been linked to gadolinium, a contrast agent used in MRI scans. More ::

09/28/2007 - Certain contrast agents used in magnetic resonance imaging -- gadolinium-based products made by Bayer AG, GE and others -- will now carry the U.S. Food and Drug Administration's strongest, "black box" warning. More ::

05/24/2007 - The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI). More ::

05/23/2007 - This updated Alert highlights FDA’s request for addition of a boxed warning and new warnings about risk of nephrogenic systemic fibrosis (NSF) to the full prescribing information for all gadolinium-based contrast agents (GBCAs) (Magnevist, MultiHance, Omniscan, OptiMARK, ProHance). More ::

05/23/2007 - The FDA today ordered black-box warnings for all gadolinium-based contrast agents for magnetic resonance imaging, detailing an increased risk for nephrogenic systemic fibrosis with kidney-disease patients. More ::

If you or a loved one have experienced Gadolinium side effects you may be entitled to compensation. Contact the Gadolinium attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Gadolinium side effects, a possible Gadolinium class action lawsuit, or any other type of Gadolinium litigation.